Literature DB >> 11790974

Comprehensive genotypic analysis of leukemia: clinical and therapeutic implications.

Louise Kelly1, Jennifer Clark, D Gary Gilliland.   

Abstract

Over the past several years, the application of a spectrum of cytogenetic and molecular diagnostic techniques has dramatically improved our understanding of the pathophysiology of leukemia. These techniques include chromosomal translocations visualized by G-banding techniques, fluorescence in-situ hybridization, spectral karyotyping, comparative genomic hybridization, loss of heterozygosity analysis, and characterization of point mutations by DNA sequence analysis. We will review the application of these techniques, update novel findings utilizing these techniques over the past year as they apply to specific leukemias, and review the clinical and therapeutic implications of these findings.

Entities:  

Mesh:

Year:  2002        PMID: 11790974     DOI: 10.1097/00001622-200201000-00003

Source DB:  PubMed          Journal:  Curr Opin Oncol        ISSN: 1040-8746            Impact factor:   3.645


  9 in total

1.  Expression profiling of CD34+ hematopoietic stem/ progenitor cells reveals distinct subtypes of therapy-related acute myeloid leukemia.

Authors:  Zhijian Qian; Anthony A Fernald; Lucy A Godley; Richard A Larson; Michelle M Le Beau
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-04       Impact factor: 11.205

2.  Hematopoiesis and leukemogenesis in mice expressing oncogenic NrasG12D from the endogenous locus.

Authors:  Qing Li; Kevin M Haigis; Andrew McDaniel; Emily Harding-Theobald; Scott C Kogan; Keiko Akagi; Jasmine C Y Wong; Benjamin S Braun; Linda Wolff; Tyler Jacks; Kevin Shannon
Journal:  Blood       Date:  2010-12-16       Impact factor: 22.113

3.  Nucleophosmin (NPM1) mutations in acute myeloid leukemia: an ongoing (cytoplasmic) tale of dueling mutations and duality of molecular genetic testing methodologies.

Authors:  Gerald Wertheim; Adam Bagg
Journal:  J Mol Diagn       Date:  2008-04-10       Impact factor: 5.568

Review 4.  Methods for the molecular analysis of cancer. An overview.

Authors:  Ken Mills
Journal:  Mol Biotechnol       Date:  2003-02       Impact factor: 2.695

5.  Somatic activation of oncogenic Kras in hematopoietic cells initiates a rapidly fatal myeloproliferative disorder.

Authors:  Benjamin S Braun; David A Tuveson; Namie Kong; Doan T Le; Scott C Kogan; Jacob Rozmus; Michelle M Le Beau; Tyler E Jacks; Kevin M Shannon
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-29       Impact factor: 11.205

6.  Patients with acute myeloid leukemia and RAS mutations benefit most from postremission high-dose cytarabine: a Cancer and Leukemia Group B study.

Authors:  Andreas Neubauer; Kati Maharry; Krzysztof Mrózek; Christian Thiede; Guido Marcucci; Peter Paschka; Robert J Mayer; Richard A Larson; Edison T Liu; Clara D Bloomfield
Journal:  J Clin Oncol       Date:  2008-06-16       Impact factor: 44.544

Review 7.  The Genomics of Myelodysplastic Syndromes: Origins of Disease Evolution, Biological Pathways, and Prognostic Implications.

Authors:  Hassan Awada; Bicky Thapa; Valeria Visconte
Journal:  Cells       Date:  2020-11-20       Impact factor: 6.600

Review 8.  Small Non-Coding RNAs in Leukemia.

Authors:  Veronica Balatti; Carlo M Croce
Journal:  Cancers (Basel)       Date:  2022-01-20       Impact factor: 6.639

9.  Association of Somatic Gene Mutations with Risk of Transformation into Acute Myeloid Leukemia in Patients with Myelodysplastic Syndrome: A Systematic Review and Meta-Analysis.

Authors:  Noorwati Sutandyo; Resti Mulyasari; Agus Kosasih; Ikhwan Rinaldi; Melva Louisa; Andi Putra Kevinsyah; Kevin Winston
Journal:  Asian Pac J Cancer Prev       Date:  2022-04-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.